Silvia Montoto

Silvia Montoto

UNVERIFIED PROFILE

Are you Silvia Montoto?   Register this Author

Register author
Silvia Montoto

Silvia Montoto

Publications by authors named "Silvia Montoto"

Are you Silvia Montoto?   Register this Author

100Publications

2804Reads

48Profile Views

Biosimilar drugs: how safe are they?

Authors:
Silvia Montoto

Leuk Lymphoma 2019 Aug 21:1-2. Epub 2019 Aug 21.

Department of Haemato-Oncology, St Bartholomew's Hospital , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1654099DOI Listing
August 2019

Localized FL: how long in response to be cured?

Authors:
Silvia Montoto

Blood 2019 01;133(3):187-188

St Bartholomew's Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-11-887489DOI Listing
January 2019

Reply to the persistent uncertainty of when to recommend allogeneic stem cell transplantation in follicular iymphoma.

Cancer 2018 08 7;124(16):3455-3456. Epub 2018 Jun 7.

Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31564DOI Listing
August 2018

Treating relapsed follicular lymphoma.

Expert Rev Hematol 2018 05 20;11(5):403-410. Epub 2018 Mar 20.

b Queen Mary University of London , London , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1453801DOI Listing
May 2018

Role of stem cell transplant in lymphoma in the era of new drugs.

Curr Opin Oncol 2017 Nov;29(6):455-459

aDepartment of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom bEuropean Society for Blood and Marrow Transplantation (EBMT)-LWP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000403DOI Listing
November 2017

Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

J Clin Oncol 2017 Oct 28;35(30):3425-3432. Epub 2017 Aug 28.

Carmen Martínez, Institute of Hematology and Oncology, Hospital Clínic; Carmen Canals, Banc de Sang i Teixits; Anna Sureda, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona; Jorge Gayoso, Hospital General Universitario Gregorio Marañón, Madrid; Arancha Bermúdez, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain; Carmen Martínez, Hervé Finel, Silvia Montoto, Peter Dreger, and Anna Sureda, European Society for Blood and Marrow Transplantation, Paris; Didier Blaise, Institut Paoli Calmettes, Marseille; Edouard Forcade, University Hospital of Bordeaux, Bordeaux; Ibrahim Yakoub-Agha, Centre Hospitalier Regional Universitaire de Lille, Lille Inflammation Research International Center, Institut National de la Santé et de la Recherche Médicale U995, Lille, France; Karl Peggs, University College London Cancer Institute; Michael Potter, The Royal Marsden Hospital; Silvia Montoto, St Bartholomew's Hospital, Barts Health National Health Service Trust, London; Stephen Robinson, Bristol Haematology and Oncology Centre, Bristol; Grant McQuaker, Gartnaval General Hospital, Glasgow; Adrian Bloor, Christie National Health Service Trust Hospital, Manchester, United Kingdom; Alida Dominietto, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, Azienda Ospedaliera-Universitaria San Martino-IST, Genova; Luca Castagna, Istituto Clinico Humanitas; Paolo Corradini, Istituto Nazionale dei Tumori, Milan; Domenico Russo, University of Brescia, Brescia, Italy; Boris Afanasyev, First Pavlov State Medical University of St Petersburg, St Petersburg, Russia; Maija Itälä-Remes, Turku University Hospital, Turku, Finland; Christof Scheid, University of Cologne, Cologne; and Peter Dreger, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6869DOI Listing
October 2017

Treatment of patients with transformed lymphoma.

Authors:
Silvia Montoto

Hematology Am Soc Hematol Educ Program 2015 ;2015:625-30

Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2015.1.625DOI Listing
October 2016

The routes for transformation of follicular lymphoma.

Curr Opin Hematol 2016 07;23(4):385-91

aCentre for Haemato-Oncology, Barts Cancer Institute bDepartment of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000255DOI Listing
July 2016

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.

AIDS 2015 May;29(8):903-10

aDepartment of Haematology, Royal Free Hospital bImperial College School of Medicine cDepartment of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust dDepartment of Haematological Medicine, King's College Hospital eDepartment of Haematology, University College Hospital fDepartment of HIV Medicine, Royal Free Hospital gResearch Department of Infection & Population Health, University College London hMortimer Market Centre, Central & North West London Foundation Trust iDepartment of HIV and Sexual Health Medicine, King's College Hospital jNational Centre for HIV Malignancy, Chelsea & Westminster Hospital, London, UK.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000623DOI Listing
May 2015

Managing HIV and Hodgkin lymphoma in the twenty-first century.

Curr Hematol Malig Rep 2014 Sep;9(3):227-32

Department of Haemato-oncology St Bartholomew's Hospital, Barts Health NHS Trust, 45 Little Britain, West Smithfield, EC1A 7BE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-014-0215-4DOI Listing
September 2014

[18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.

J Clin Oncol 2014 Jun 5;32(17):1769-75. Epub 2014 May 5.

Maurizio Martelli and Erica Finolezzi, Sapienza University, Rome; Pier Luigi Zinzani and Stefano A. Pileri, Policlinico S. Orsola-Malpighi, Bologna; Andrés J.M. Ferreri, San Raffaele Scientific Institute, Milan; Umberto Vitolo, Azienda Ospedaliera S. Giovanni Battista, Torino; Caterina Stelitano, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria; Ercole Brusamolino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia; Maria Giuseppina Cabras, Ospedale Businco, Cagliari; Luigi Rigacci, Policlinico Careggi, Florence; Monica Balzarotti, IRCCS Humanitas, Rozzano; Flavia Salvi, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy; Luca Ceriani, Emanuele Zucca, Franco Cavalli, and Luca Giovanella, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Silvia Montoto, Barts Cancer Institute, London; Andrew Davies and Peter W.M. Johnson, University of Southampton, Southampton, United Kingdom; and Armando Lopez-Guillermo, Hospital Clinic, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.7524DOI Listing
June 2014

The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma.

Nucl Med Commun 2014 Mar;35(3):311-5

aCentre for Haemato-Oncology bDepartment of Nuclear Medicine, Centre for Molecular Oncology, Barts Cancer Institute cClinical PET Centre, Division of Imaging Sciences and Biomedical Engineering, Kings College London, St Thomas' Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000059DOI Listing
March 2014

HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era.

AIDS 2014 Mar;28(5):689-97

aCentre for Haemato-Oncology, Barts Cancer Institute, QMUL bMedical Oncology, Chelsea and Westminster Hospital cHaematological Medicine, King's College Hospital dDepartment of Haematology, Royal Free Hospital eHaematology, Guys and St Thomas Hospital fDepartment of Oncology, Brighton and Sussex University Hospital, Brighton gDepartment of Sexual Health, King's College Hospital hHIV medicine, Royal Free Hospital iInfection and Immunity, Barts Health NHS Trust jHaemato-Oncology Department, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000133DOI Listing
March 2014

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

J Clin Oncol 2014 Feb 16;32(4):273-81. Epub 2013 Dec 16.

Timothy S. Fenske and Mehdi Hamadani, Medical College of Wisconsin; Mei-Jie Zhang, Jeanette Carreras, and Parameswaran N. Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Ernesto Ayala, H. Lee Moffitt Cancer Center and Research Institute, Tampa; Baldeep M. Wirk, Shands Healthcare and University of Florida, Gainesville, FL; Linda J. Burns, University of Minnesota Medical Center, Fairview, Minneapolis; David J. Inwards, Mayo Clinic Rochester, Rochester, MN; Amanda Cashen, Barnes Jewish Hospital, Washington University School of Medicine, St. Louis, MO; Luciano J. Costa, Medical University of South Carolina, Charleston, SC; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center, San Antonio, TX; Robert P. Gale, Imperial College; Silvia Montoto, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Leona A. Holmberg and David G. Maloney, Fred Hutchinson Cancer Research Center, Seattle, WA; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Reinhold Munker, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA; Miguel-Angel Perales, Memorial Sloan-Kettering Cancer Center, New York, NY; David A. Rizzieri, Duke University Medical Center, Durham, NC; Harry C. Schouten, Academische Ziekenhuis Maastricht, Maastricht, the Netherlands; Sonali M. Smith, University of Chicago Hospitals, Chicago, IL; Edmund K. Waller, Emory University Hospital, Atlanta, GA; and Ginna G. Laport, Stanford Hospital and Clinics, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897255PMC
February 2014

Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.

Biol Blood Marrow Transplant 2013 Dec 3;19(12):1740-4. Epub 2013 Oct 3.

Division of Blood and Marrow Transplant, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.09.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906436PMC
December 2013

Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in Haematology.

Br J Haematol 2013 Oct 27;163(2):168-81. Epub 2013 Aug 27.

Nottingham University Hospitals NHS Trust, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12509DOI Listing
October 2013

The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.

Future Oncol 2013 Jun;9(6):807-15

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.13.55DOI Listing
June 2013

Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.

Cancer 2012 Nov 17;118(21):5270-7. Epub 2012 Apr 17.

The Warren Alpert Medical School of Brown University, Division of Hematology and Oncology, The Miriam Hospital, Providence, RI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27551DOI Listing
November 2012

Management of localized-stage follicular lymphoma: changing the paradigm?

Authors:
Silvia Montoto

J Clin Oncol 2012 Sep 20;30(27):3328-9. Epub 2012 Aug 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.5768DOI Listing
September 2012

An innovative joint approach to HIV and lymphoma care.

Sex Transm Infect 2012 Feb 1;88(1):71. Epub 2011 Dec 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/sextrans-2011-050402DOI Listing
February 2012

Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.

J Clin Oncol 2011 Dec 31;29(35):4696-701. Epub 2011 Oct 31.

National Centre for Human Retrovirology, St Mary’s Hospital, Imperial College Healthcare National Health Service Trust, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2011.35.5578
Publisher Site
http://dx.doi.org/10.1200/JCO.2011.35.5578DOI Listing
December 2011

Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies.

Br J Haematol 2011 Aug 20;154(4):448-56. Epub 2011 Jul 20.

Centre for Haemato-Oncology, Barts Cancer Institute, Barts and the London School of Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08744.xDOI Listing
August 2011

Transformation of indolent B-cell lymphomas.

J Clin Oncol 2011 May 11;29(14):1827-34. Epub 2011 Apr 11.

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, 45 Little Britain, EC1A 7BE, London, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2010.32.7577
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.32.7577DOI Listing
May 2011

SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.

Blood 2011 Mar 13;117(11):3147-50. Epub 2011 Jan 13.

Centre for Haemato-Oncology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-10-315382DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062316PMC
March 2011

Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study.

Am J Hematol 2011 Mar 15;86(3):256-61. Epub 2011 Feb 15.

Division of Hematology and Oncology, The Miriam Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21947DOI Listing
March 2011

Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.

Nat Rev Clin Oncol 2010 Dec;7(12):677-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2010.186DOI Listing
December 2010

Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management.

Haematologica 2010 Jul 27;95(7):1130-5. Epub 2010 Jan 27.

CR-UK Medical Oncology Unit, St Bartholomew's Hospital, Barts and the London School of Medicine and Dentistry, 45 Little Britain, EC1A 7BE. London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.020115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895037PMC
July 2010

Molecular signatures in the diagnosis and management of follicular lymphoma.

Curr Opin Hematol 2010 Jul;17(4):333-40

Centre for Medical Oncology, Barts and the London School of Medicine, Queen Mary University of London, Charterhouse Square, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e328338ccabDOI Listing
July 2010

Follicular lymphoma: managing an indolent malignancy.

Br J Hosp Med (Lond) 2010 May;71(5):258-62

Centre for Meidcal Oncology, Barts, and the London School of Medicine, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2010.71.5.47905DOI Listing
May 2010

Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.

Crit Rev Oncol Hematol 2008 Aug 21;67(2):172-85. Epub 2008 May 21.

Hematology Unit, Azienda Ospedaliera S. Giovanni Battista Molinette, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2008.03.008DOI Listing
August 2008

Follicular lymphomas.

Crit Rev Oncol Hematol 2008 Jun 21;66(3):248-61. Epub 2008 Mar 21.

Hematology Unit, Azienda Ospedaliera S. Giovanni Battista Molinette, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2008.01.014DOI Listing
June 2008

Oncologic, endocrine & metabolic emerging drugs in B-cell non-Hodgkin's lymphoma.

Expert Opin Emerg Drugs 2008 Jun;13(2):323-43

St Bartholomew's Hospital, 38 Little Britain, London EC1A 7BE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.13.2.323 DOI Listing
June 2008

Brief communication: rituximab in HIV-associated multicentric Castleman disease.

Ann Intern Med 2007 Dec;147(12):836-9

Department of Oncology, Imperial College, The Chelsea and Westminster Hospital, Barts and the London NHS Trust, and Queen Mary's University, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-147-12-200712180-00003DOI Listing
December 2007